Analyst firms · Argus Research · HUM
Argus Research HUM price target and rating history
Humana Inc. (HUM) · Health Care
Argus Research rates Humana Inc. (HUM) Hold with a $550 price target, as of its latest action on Mar 13, 2024. It has published 3 rating actions on HUM since June 2023, including 1 upgrade and 2 downgrades. Across 12 firms with a HUM price target in the last 12 months, the median target is $501.
- Current rating
- Hold
- Price target
- $550
- Median target, all firms
- $501
- Actions on HUM
- 3
Every Argus Research rating on HUM
- Mar 13, 2024
- Dec 12, 2023
- Jun 23, 2023
How other firms rate HUM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Outperform | $563 | Nov 16, 2026 |
| Raymond James | Outperform | $520 | Oct 12, 2026 |
| Robert W. Baird | Outperform | $596 | Oct 9, 2026 |
| Cantor Fitzgerald | Overweight | $460 | Oct 7, 2026 |
| Barclays | Overweight | $515 | Sep 25, 2026 |
| Morgan Stanley | Equal-Weight | $370 | Aug 5, 2026 |
| Evercore ISI | Outperform | $480 | Jul 30, 2026 |
| Leerink Partners | Outperform | $513 | Jul 30, 2026 |
| BofA Securities | Buy | $500 | Jul 29, 2026 |
| Wells Fargo | Overweight | $502 | Jul 13, 2026 |
| Deutsche Bank | Buy | $441 | May 20, 2026 |
| Jefferies | Buy | $313 | Dec 5, 2025 |
Questions about Argus Research and HUM
- What is Argus Research's price target for HUM?
- Argus Research's latest stated price target for Humana Inc. (HUM) is $550, from its action on Dec 12, 2023.
- What is Argus Research's rating on HUM?
- Argus Research rates HUM Hold, a neutral rating, as of Mar 13, 2024.
- When did Argus Research last change its view on HUM?
- On Mar 13, 2024, Argus Research downgrades to Hold from Buy.
- How does Argus Research's HUM target compare with other analysts?
- Across 12 firms with a HUM price target in the last 12 months, the median target is $501.
More HUM rating histories
- RBC Capital Markets3
- Raymond James4
- Cantor Fitzgerald3
- Barclays5
- Morgan Stanley10
- Leerink Partners5
- BofA Securities6
- Wells Fargo5
- Deutsche Bank4
- Goldman Sachs3
All Argus Research ratingsHUM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.